Transcriptomics

Dataset Information

0

RNAseq Study in CC-671 Treated Cal-51 Cells


ABSTRACT: CC-671 has been identified as an inhibitor of Cdc2-like kinase 2 (CLK2) and TTK in direct enzyme assays. CLK2 is a member of the CLK family that phosphorylates serine- and arginine-rich (SR) proteins of the spliceosomal complex as part of a regulatory mechanism for control of pre-mRNA splicing. SR proteins are a family of small nuclear ribonucleoprotein particle (snRNP) splicing factors involved in constitutive and alternative splicing. Monitoring specific phospho-biomarkers of CLK2 demonstrated that CC-671 inhibited phosphorylation of CLK2 substrates in cancer cells with mean IC50 of 549 nM in the triple negative breast cancer (TNBC) line CAL51. In this study, RNA sequencing approach was used to quantify the impact of CC-671 treatment on gene transcription and global alternative splicing in CAL51 cells. Differential exon usage analysis demonstrated that CC-671 changed alternative splicing of many genes. In addition, different sets of genes are impacted by CC-671 at both the alternative splicing and mRNA expression. Genes impacted by alternative splicing shared a set of common pathways with genes altered by mRNA expression. This result indicates that CC-671 regulates transcription via both gene expression and alternative splicing mechanisms.

ORGANISM(S): Homo sapiens

PROVIDER: GSE113426 | GEO | 2018/04/23

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-07-15 | GSE271918 | GEO
2023-11-09 | GSE227673 | GEO
2010-09-01 | E-GEOD-22963 | biostudies-arrayexpress
2008-12-30 | E-GEOD-11491 | biostudies-arrayexpress
| PRJNA946311 | ENA
| PRJNA451158 | ENA
2008-12-31 | GSE11491 | GEO
2023-11-09 | GSE247417 | GEO
2023-11-09 | GSE247419 | GEO
2011-12-22 | GSE28672 | GEO